2015
DOI: 10.1016/j.apradiso.2014.09.011
|View full text |Cite
|
Sign up to set email alerts
|

Radioiodination of 2,3-dimethyl-4H-furo[3,2-c]coumarin and biological evaluation in solid tumor bearing mice

Abstract: Compound 2,3-dimethyl-4H-furo[3,2-c]coumarin is a coumarin derivative that could be labeled with 125I. The process of labeling was started using 1 mg of the compound, 50 µg CAT oxidizing agent, 30 min as reaction time at pH with a yield about 95%. The 125I-coumarin derivative was stable for about 48 h. Radiochemical purity of the labeled compound was performed by electrophoresis and HPLC. The labeled compound was separated with purity about 95%. Tumor transplantation to produce a solid tumor in the right leg o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…The results (5% uptake) supported the potential use of this heterocycle as a probe for imaging of tumor sites. 46…”
Section: Bioactivities Of Some Furo[32-c] Coumarinsmentioning
confidence: 99%
“…The results (5% uptake) supported the potential use of this heterocycle as a probe for imaging of tumor sites. 46…”
Section: Bioactivities Of Some Furo[32-c] Coumarinsmentioning
confidence: 99%
“…Among the three most active compounds, the highest was achieved for compound 75b (IC 50 8.17 ± 1.89 µM and 3.15 ± 1.68 µM), being more potent against the gastric carcinoma (MGC803) cell lines. This is an indication that not only the nature but also the position of the substituent affects the anticancer activity.Mohammed et al[115], based on the literature survey regarding the antitumor activity of coumarin compounds[116,117] as well as thiazole derivatives[118], combined these two moieties in one molecule and synthesized the potassium salt of 5-(4-chlorophenyl)-2-[(7hydroxycoumarin-3-ylethylidene)acetylhydrazine]-1,3-thiazole (76a) and 5-(4-chlorophenyl)-2-[(8-hydroxycoumarin-3-ylethylidene)acetylhydrazine]-1,3-thiazole (76b) with the aim to investigate in vivo their antitumor activity (Figure29). Compounds were tested for their effect on caspase-3 and Bax (BCL-2 associated protein) in Ehrlich ascites carcinoma (EAC) and in the liver.…”
mentioning
confidence: 99%
“…Coumarin compounds possessing anti-bacterial [6,7], Antifungal [8][9][10], anticoagulant [11], antituberculosis [12], anti-inflammatory [11], antitumor [13,14], anti-human immunodeficiency virus (HIV) activities [15]. Its substitution effectively influences the biological activities of the synthesized coumarin derivatives.…”
Section: Introductionmentioning
confidence: 99%